Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Much of what we know about insulin resistance is based on studies from metabolically active tissues such as the liver, adipose tissue, and skeletal muscle. Emerging evidence suggests that the vascular endothelium plays a crucial role in systemic insulin resistance; however, the underlying mechanisms remain incompletely understood. Arf6 (ADP ribosylation factor 6) is a small GTPase that plays a critical role in endothelial cell function. Here, we tested the hypothesis that the deletion of endothelial Arf6 will result in systemic insulin resistance.METHODS:We used mouse models of constitutive endothelial cell–specific Arf6 deletion (Arf6f/−Tie2Cre) and tamoxifen-inducible Arf6 knockout (Arf6f/fCdh5CreER+). Endothelium-dependent vasodilation was assessed using pressure myography. Metabolic function was assessed using a battery of metabolic assessments including glucose and insulin tolerance tests and hyperinsulinemic-euglycemic clamps. We used a fluorescence microsphere–based technique to measure tissue blood flow. Skeletal muscle capillary density was assessed using intravital microscopy.RESULTS:Endothelial Arf6 deletion impaired insulin-stimulated vasodilation in white adipose tissue and skeletal muscle feed arteries. The impairment in vasodilation was primarily due to attenuated insulin-stimulated NO bioavailability but independent of altered acetylcholine-mediated or sodium nitroprusside–mediated vasodilation. Endothelial cell–specific deletion of Arf6 also resulted in systematic insulin resistance in normal chow–fed mice and glucose intolerance in high-fat diet–fed obese mice. The underlying mechanisms of glucose intolerance were reductions in insulin-stimulated blood flow and glucose uptake in the skeletal muscle and were independent of changes in capillary density or vascular permeability.CONCLUSIONS:Results from this study support the conclusion that endothelial Arf6 signaling is essential for maintaining insulin sensitivity. Reduced expression of endothelial Arf6 impairs insulin-mediated vasodilation and results in systemic insulin resistance. These results have therapeutic implications for diseases that are associated with endothelial cell dysfunction and insulin resistance such as diabetes.

Endothelial Notch signaling controls insulin transport in muscle

Endothelial metabolic control of insulin sensitivity through resident macrophages

Endothelial β1 Integrins are Necessary for Microvascular Function and Glucose Uptake

Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat

Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1

Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis.

Endothelial ERα Promotes Glucose Tolerance by Enhancing Endothelial Insulin Transport to Skeletal Muscle.

Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin

Endothelial-Specific Reduction in Arf6 Impairs Insulin-Stimulated Vasodilation and Skeletal Muscle Blood Flow Resulting in Systemic Insulin Resistance in Mice

Microvascular insulin resistance associates with enhanced muscle glucose disposal in CD36 deficiency

Notch signaling in adipose tissue macrophages prevents diet‐induced inflammation and metabolic dysregulation

Enhanced ECCD36 Signaling Promotes Skeletal Muscle Insulin Resistance in Female Mice

Insulin evokes release of endozepines from astrocytes of the NTS to modulate glucose metabolism

The Signaling Network Controlling RabGAPs and Contraction-Mediated Glucose Uptake in Skeletal Muscle

Egr-1 Decreases Adipocyte Insulin Sensitivity by Tilting Pi3k/Akt and Mapk Signal Balance in Mice

Insulin signalling in tanycytes gates hypothalamic insulin uptake and regulation of AgRP neuron activity

Endothelial APLNR Regulates Tissue Fatty Acid Uptake and is Essential for Apelin's Glucose-Lowering Effects.

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis

Insulin Modulates Ischemia-Induced Endothelial Progenitor Cell Mobilization and Neovascularization in Diabetic Mice